The records of 113 consecutive patients with a suspected gastrointestinal motility disorder referred between January 1988 and July 1991 were retrospectively reviewed. The aims were to identify the prevalence of autonomic dysfunction in those with or without associated neurological disease and to determine the diagnostic value of testing for autonomic dysfunction. All 
syndrome nine of 33, idiopathic upper gastrointestinal dysmotility six of 21, diabetes mellitus nine of 13 , identified non-diabetic neurological syndromes six ofnine, postvagotomy or abdominal surgery three of 11, and myopathic pseudo-obstruction two of seven. Autonomic testing is useful in the assessment of autonomic involvement outside the gastrointestinal tract. Logistic discriminant analysis showed that autonomic function testing did not add to the diagnostic value of motility tests in distinguishing between patients with and without irritable bowel syndrome, although a slight improvement was indicated for identifying neuropathic dysmotilities. Thus, the aetiological role of general autonomic dysfunction in irritable bowel syndrome and idiopathic and postvagotomy dysmotilities deserves further study. The The maximum score of 11-0, in a subject who has not had prior gastric surgery, is possible if all of the italicised scores in the above table are scored. For this subject, an absolute score -3 is abnormal. MMC-=migrating motor complex. Results of autonomic function tests were compared with normal data, matched for age and sex. The scoring system used is shown in Table   II . An a priori cut off of >-3 was used to identify autonomic dysfunction in each patient. A relative autonomic dysfunction score was also computed for each patient using the maximum raw score of 9.
STATISTICAL ANALYSIS
A logistic discriminant analysis'9 using both relative autonomic function and motility scores of all patients, except those with idiopathic Among the remaining subgroups of patients, the prevalence of autonomic dysfunction ranged from 27-29%.
CORRELATION BETWEEN AUTONOMIC AND MOTILITY SCORES
There was a significant (p<0O05) but modest (r=0-26) rank correlation between autonomic and motility scores in the entire group. In the subgroup of patients with diabetes mellitus, this correlation was stronger (r=0-68; p=001); similarly, a significant correlation was noted in the combined group of patients with diabetes mellitus and non-diabetic neurological syndromes (n=22; r=0-49; p<0 05).
LOGISTIC DISCRIMINANT ANALYSIS
The model based on data from patients with diabetes mellitus and identified neurological syndromes showed that at a specificity of72%, the addition of the autonomic function score to the motility score increased the sensitivity for identifying a neuropathic disturbance from 73 to only 76% (Fig 3) . In this analysis the addition of the autonomic score changed the corresponding cut off in predicted probability of a neuropathic disturbance from 0-376 for the motility score alone to 0 394 for the combined motility and autonomic scores.
The second logistic discriminant model could distinguish irritable bowel syndrome from nonirritable bowel syndrome patients at a specificity of 80%, with a sensitivity of 90%. Once again, the autonomic function score did not increase the accuracy of the motility test to differentiate these two groups (Fig 4) . Our data also suggest that autonomic dysfunction may result in gastrointestinal dysmotility of varying severity. Some of these dysmotilities are manifest clinically and on special testing (for example by manometry) as either irritable bowel syndrome or idiopathic upper gastrointestinal motility disorders. In some patients the symptoms may have been severe enough to lead to surgical treatment before referral to our clinic.
Discussion
Read'7 has elegantly indicated the difficulty in categorising the spectrum of more severely affected patients with apparently functional gastrointestinal disease. While intestinal manometric criteria may help make this distinction,8 the similar prevalence of dysautonomia found in our study provides support for Read Table II . A maximum score of9 was used to obtain relative scores for each patient.
that the terms irritable bowel syndrome and pseudo-obstruction may merely 'describe' different categories in the spectrum of functional gastrointestinal disease. '7 The second major objective of our study was to evaluate the diagnostic utility of autonomic function testing. Based on the fact that a similar proportion of patients with irritable bowel syndrome, idiopathic upper gastrointestinal dysmotility, and previous surgery in our series had autonomic dysfunction one would correctly anticipate that these tests would not permit a clear distinction of the irritable bowel syndrome group from the rest. Indeed, the logistic discriminant models showed that autonomic tests did not add to the diagnostic value of the motility study. Among patients with diabetes and other identifiable neurological syndromes, autonomic tests were abnormal in 69%, compared with the motility test which was abnormal in 73%. Thus, if motility testing is not available, the non-invasive autonomic tests may be useful in confirming the presence ofvisceral denervation in those patients with symptoms suggestive of gut dysmotility. It must also be stressed that autonomic testing is extremely useful in assessing autonomic involvement outside the gastrointestinal tract.
Two patients with hollow visceral myopathy had abnormal vasomotor and sudomotor responses. The low amplitude fasting and postprandial intestinal pressure profiles suggested a myopathic disorder. Thus, the occurrence of visceral or vasomotor autonomic dysfunction does not necessarily imply that the gut dysmotility is the result of the neuropathic dysfunction.
Since only 27-29% of patients with idiopathic upper gastrointestinal dysmotility or postabdominal surgery have evidence of autonomic dysfunction, it is possible that disorders of the efferent extrinsic neurological pathways are not aetiologically important in these conditions. However, it is important to note that our data do not assess visceral afferent function or the enteric nervous system, which are presently believed to be at least partly responsible for the development of symptoms or abnormal motor function in the functional gastrointestinal syndromes. Among patients with previous vagotomy, it is likely that abdominal vagal denervation, which was not tested in our study, resulted in gastrointestinal dysmotility.9
Within the constraint dictated by a tertiary referral centre, we believe our study of 113 consecutive patients is unique since it encompasses all major subclasses of motility disorders from idiopathic dysmotility to gut motor dysfunction secondary to identifiable neurological syndromes. The standardisation of motility and autonomic tests and high proportion (83%) of patients who underwent both tests allow estimates of the prevalence of autonomic dysfunction among patients referred to a centre specialising in gut motility disorders. Autonomic dysfunction is frequent among patients with identifiable neurological syndromes who present with gastrointestinal symptoms. Autonomic dysfunction of an idiopathic nature is present in a minority of patients with functional gastro-1.0 r- Table I . Relative score were obtainedfrom dividing the maximum possible for an individual patient. 
